tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market

Akebia Therapeutics (AKBA) Stock Investors

Compare
1,434 Followers
Based on 802,564 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AKBA
On average, investors allocate 4.10% of their portfolios to AKBA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 802,564 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AKBA

3.4%
Last 7
Days
1.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AKBA, out of 802,564 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AKBA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.00%
$2.14
Increased
3.74%
$2.89
Based on the activity of investors who made their portfolios public
The table shows changes in AKBA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AKBA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.81%
-0.74%
-4.92%
3.03B
Healthcare
DraftKings
4.26%
+0.44%
+3.75%
30.98B
Consumer Cyclical
Nio
8.12%
-0.32%
-4.65%
7.40B
Consumer Cyclical
CVS Health
3.98%
-0.28%
-2.96%
80.42B
Healthcare
Riot Platforms
4.49%
-0.63%
-3.37%
3.39B
Financial
Abbott Laboratories
3.32%
-0.81%
-3.32%
231.33B
Healthcare
Marathon Digital Holdings
4.88%
-0.46%
-3.52%
5.51B
Financial
JD
4.51%
-0.34%
-0.53%
51.59B
Consumer Cyclical
Block
3.51%
-1.19%
-5.09%
39.28B
Technology
Delta Air Lines
4.53%
-0.64%
-3.57%
31.98B
Industrials
Based on the activity of 802,564 active portfolios
Open your Smart Portfolio

AKBA Investor Analysis

AKBA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.1%
of AKBA holders
are under 35
Average Segment Performance
Average P/E Ratio10.99
Beta4.52
Dividend Yield4.11%
AKBA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.9%
of AKBA holders
are between 35–55
Average Segment Performance
Average P/E Ratio5.01
Beta11.31
Dividend Yield3.48%
AKBA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
34.9%
of AKBA holders
are over 55
Average Segment Performance
Average P/E Ratio1.85
Beta4.79
Dividend Yield3.82%
Overview of age group and performance of AKBA stock investors
See who invests in AKBA according to age group and performance.

FAQ

How many retail Investors hold AKBA?
<0.1% of TipRanks' retail investors hold AKBA in their portfolios.
    What is AKBA Investor Sentiment?
    AKBA’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of AKBA in the last 7 days?
      ▲ 3.4% of TipRanks' retail investors changed their holding of AKBA in the last 7 days.
        What percentage of retail investors changed their holding of AKBA in the last 30 days?
        ▼ 1.6% of TipRanks' retail investors changed their holding of AKBA in the last 30 days.
          What is the average age of retail investors who hold AKBA?
          The average age of AKBA Holders is between 35–55.
            What other stocks have AKBA investors also bought?
            AKBA Investors also bought VKTX, DKNG, NIO, CVS, RIOT, ABT, MARA, JD, XYZ, DAL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis